Home/Alchem Laboratories/Otto Geoffroy, Ph.D.
OG

Otto Geoffroy, Ph.D.

Director of Research

Alchem Laboratories

Alchem Laboratories Pipeline

DrugIndicationPhase
EndoxifenBreast CancerPhase 1/2
UAB30Non-melanoma Skin Cancer PreventionPhase 1
TriapineVarious Cancers (Cervical, Neuroendocrine, Uterine)Phase 1/2
4'-Thio-2'-Deoxycytidine (TdCyd)Advanced Solid TumorsPhase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC)Advanced Solid TumorsPhase 1